USPTO serial 98863619
BIOSINT
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DIBLE, JONATHON I
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with BIOSINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
POMEZIA (RM), IT
POMEZIA (RM), IT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DEBORAH L. CORPUS
DEBORAH L. CORPUS Chrisman Gallo Tochtrop LLC629 Euclid Avenue, Suite 1101CLEVELAND, OH 44114United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances and biological preparations for the pharmaceutical, nutritional, and food industries, namely, carnitine and its salts and chemical derivates for use in the manufacture of pharmaceutical preparations, dietary supplements, and foodstuffs; Chemical substances, namely, carnitine and its salts and chemical derivates for the manufacture of pharmaceuticals, dietary supplements, and foodstuffs; All the aforementioned goods not for use in or with dental wax, dental and odontoiatric coating materials, materials for stopping teeth, and materials for zootechnics | ACTIVE | — |
| 005 | Chemical and biological preparations for pharmaceutical use, namely, pharmaceutical preparations containing L-carnitine and its salts and chemical derivatives for the treatment and prevention of cardiovascular diseases, cancer diseases, kidney diseases, diseases and disorders of fat and glucose metabolism, primary and secondary L-carnitine deficiency, male infertility, mental and cognitive diseases, liver diseases, HIV and AIDS, tissue trauma and sepsis, malnutrition, aging, and bone loss; Chemical and biological preparations for medical use in the diagnosis of cardiovascular diseases, cancer diseases, kidney diseases, diseases and disorders of fat and glucose metabolism, primary and secondary L-carnitine deficiency, male infertility, mental and cognitive diseases, liver diseases, HIV and AIDS, tissue trauma and sepsis, malnutrition, aging, and bone loss; Dietetic substances and foodstuffs adapted for medical use containing L-carnitine and its salts and chemical derivatives; All the aforementioned goods not for use in or with dental wax, dental or odontoiatric coating materials, material for stopping teeth, and material for zootechnics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 10, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 10, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 10, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 25, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 24, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 22, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 10, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 23, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 23, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2024 | NWAP | NEW APPLICATION ENTERED | — |